Mayor of COVID-19 hotspot Banff says she’s disappointed over J&J vaccine delays

The mayor of a COVID-19 hot spot in Alberta says she’s disappointed that Johnson & Johnson vaccines earmarked for her community are delayed, but values the work Health Canada is doing to ensure every dose is safe.

Banff Mayor Karen Sorensen issued a statement saying front-line workers need the vaccines.

Read more: Banff mayor sees increased need for COVID-19 vaccinations in younger demographics

She also thanked provincial health officials for exploring other sources to help immunize high-risk areas as soon as possible.

Residents of Banff were among several priority groups across Canada looking forward to the promise of J&J shipments next week.

Click to play video: 'Vaccination Acceleration' Vaccination Acceleration

Vaccination Acceleration

Plans to distribute the first 300,000 doses are on hold after Health Canada learned part of the vaccines were manufactured at a Maryland facility that messed up the ingredients in 15 million doses bound for the U.S. market.

Story continues below advertisement

Health Canada says it’s seeking information from the FDA and Johnson & Johnson’s pharmaceutical arm, Janssen, to determine if the doses shipped to Canada meet required safety standards.

“Like other communities, we will wait our turn and remain vigilant in following all health protocols to stop the spread until everyone is immunized,” Sorensen says.

Read more: Alberta changes COVID-19 vaccine rollout to support RMWB and Banff

The Emergent Biosolutions facility in Baltimore was recently cited by the U.S. Food and Drug Administration for violations including cleaning and sterilization failures, the potential for cross-contamination and failure to follow required protocols.

Health Canada had already cleared 1.5 million doses of the Oxford-AstraZeneca vaccine made at the facility, but did not think the Canadian Johnson & Johnson doses had any connection to that plant.

Now Health Canada says the drug substance that makes up part of the Johnson & Johnson vaccine was actually produced there and then shipped elsewhere for the vaccines to be completed.

Read more: COVID-19 hospitalizations, ICU admissions growing for younger Canadians amid 3rd wave

Word of the delay came hours before a number of COVID-19 hot spots reported continued high case counts and troubling virus-related hospitalization rates, though there were signs of hope in some jurisdictions.

Story continues below advertisement

While Ontario recorded 900 patients in its intensive care units for the first time since the onset of the pandemic, overall hospitalizations dipped slightly to 2,152. The province recorded 3,369 new infections.

Hospitalizations also declined in Quebec for the fourth straight day, with the province reporting 578 patients seeking treatment for COVID-19. The province also added 1,101 new infections to its overall tally.

Nova Scotia recorded a single-day high for new cases with 148, though Premier Iain Rankin had warned residents of an impending spike as provincial laboratories work their way through a testing backlog.

© 2021 The Canadian Press

View Source